[Form 4] INSPIRE VETERINARY PARTNERS, INC. Insider Trading Activity

Rhea-AI Filing Summary

Erinn Thomas-Mackey, a director of Inspire Veterinary Partners, Inc. (IVP), reported acquiring 1,447 shares of Class A common stock through the exercise of a stock option on 09/26/2024. The option had a listed exercise price of $17 and the transaction leaves Ms. Thomas-Mackey with 1,447 shares held directly. The Form 4 notes the reported share amounts were adjusted for a 25-for-1 reverse stock split effected by the issuer on 01/27/2025.

The filing also discloses that this Form 4 was submitted late due to an inadvertent administrative error and bears a signature date of 09/22/2025.

Positive

• Director acquired shares through option exercise, increasing direct ownership to 1,447 shares.
• Reverse split adjustment disclosed, clarifying that reported share counts reflect the 25-for-1 consolidation.

Negative

• Late Form 4 filing disclosed, attributed to an inadvertent administrative error, raising compliance concerns.

Insights

Securities Analyst

TL;DR: Director exercised options for 1,447 shares at $17; small direct holding, limited market impact.

The filing documents a standard option exercise by a company director yielding 1,447 shares of Class A common stock, with an exercise price shown as $17. The transaction date is 09/26/2024 and the beneficial ownership is reported as direct. Adjustments for a 25:1 reverse split on 01/27/2025 are disclosed, indicating the reported share counts reflect post-split figures. From a trading-impact perspective, the disclosed share quantity appears modest and is unlikely to be material to company capitalization, though precise materiality cannot be determined from this Form 4 alone.

Corporate Governance Expert

TL;DR: Exercise is routine but the late filing raises governance and compliance concerns.

The Form 4 shows a routine insider option exercise, yet the registrant acknowledges the Form was filed late due to an administrative error. Timely Section 16 reporting is a basic compliance obligation; late filings can attract regulatory scrutiny and undermine investor confidence in disclosure controls. The disclosure of the reverse stock split adjustment is appropriate and clarifies share counts.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thomas-Mackey Erinn

(Last) (First) (Middle)

780 LYNNHAVEN PARKWAY

SUITE 400

(Street)

VIRGINIA BEACH VA 23452

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INSPIRE VETERINARY PARTNERS, INC. [ IVP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/26/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$17	09/26/2024		A		1,447		09/26/2024	09/26/2034	Class A Common Stock	1,447	$0	1,447(1)	D

Explanation of Responses:

1. On January 27, 2025, the issuer effected a 25 to 1 reverse stock split of its Class A Common Stock. The number of shares of Class A Common Stock reported on this Form 4 has been adjusted to reflect the reverse stock split.

Remarks:

This Form 4 is being filed late due to inadvertent administrative error.

	/s/ Erinn Thomas-Mackey	09/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares did Erinn Thomas-Mackey acquire according to the Form 4 for IVP?

The Form 4 reports an acquisition of 1,447 shares of Class A common stock.

What was the exercise price for the option exercised on 09/26/2024?

The reported exercise price of the stock option was $17.

Does the filing mention any corporate actions affecting share counts for IVP?

Yes. The Form 4 states a 25-for-1 reverse stock split was effected on 01/27/2025 and the share numbers were adjusted accordingly.

Was the Form 4 filed on time?

No. The filer states the Form 4 was filed late due to an inadvertent administrative error.

What is the reporting person’s relationship to IVP?

Erinn Thomas-Mackey is reported as a Director of Inspire Veterinary Partners, Inc.